CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- 4 Grant or award President & CEO acquired 66,300 shares (grant or award)
- 4 Grant or award President & CEO acquired 135,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 15,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award President & CEO acquired 245,072 shares (grant or award)
- 4 Grant or award Co-Chief Executive Officer acquired 241,935 shares (grant or award)
- 4 Grant or award EVP & Chief Business Officer acquired 109,426 shares (grant or award)
- 4 Grant or award See Remarks acquired 65,246 shares (grant or award)
- 4 Grant or award President & CEO acquired 305,198 shares (grant or award)
- 4 Open-market buy Co-Chief Executive Officer bought 11,500 shares at $1.77 ($20,402)
- 4 Grant or award Co-Chief Executive Officer acquired 35,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 31,185 shares (grant or award)
- 4 Grant or award Director acquired 11,999 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Medical Officer acquired 35,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award President & Co-CEO acquired 75,000 shares (grant or award)
- 4 Grant or award Co-Chief Executive Officer acquired 75,000 shares (grant or award)
- 4 Grant or award Co-Chief Executive Officer acquired 35,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 31,185 shares (grant or award)
Page 3 of 17 · 329 filings